Skip to main content

GSA CAPITAL PARTNERS LLP

Position in CORT — Corcept Therapeutics Inc

CIK 1362033 LONDON, X0

Position in CORT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$2,022,196
+$1,144,930 QoQ
Shares Held
23,257
+6.9% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#150
of 415 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CORT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. CORT ranks #8 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 CORT
Corcept Therapeutics Inc
This page
23,257 $2,022,196

All Filings in CORT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,022,196 23,257
2026-03-31 $877,266 21,763
2025-06-30 $851,660 11,603
2025-03-31 $2,478,916 21,703
2024-12-31 $2,110,131 41,876
2024-06-30 $1,013,850 31,205
2024-03-31 $763,634 30,315
2023-12-31 $1,338,500 41,210
2023-09-30 $1,664,675 61,089
2023-06-30 $2,079,485 93,460
2023-03-31 $2,007,643 92,689
2022-12-31 $2,523,030 124,226
2022-09-30 $671,921 26,206
2022-06-30 $349,661 14,704
2022-03-31 $266,028 11,813
2021-09-30 $416,310 21,154